
ANAMNESE
Medical artificial intelligence that questions the patient through a web interface or a chatbot.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
€1.6m | Seed | ||
Total Funding | 000k |
EUR | 2019 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 72 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Anamnèse is an e-health company that develops Software-as-a-Service (SaaS) solutions to digitize and improve healthcare pathways. Founded in 2017 by Jérôme Bourreau, the company was incubated at the prestigious École Polytechnique in France. The firm's core mission is to enhance the efficiency of healthcare professionals and the overall patient experience by leveraging digital tools and artificial intelligence. This approach aims to address systemic challenges such as the shortage of healthcare professionals and to transform patient waiting time into medically productive time.
The company's business model is centered on providing its modular e-health platform to a diverse client base across three primary markets: community care (practitioners, clinics), hospitals, and preventive medicine for organizations like corporations and universities. For community and hospital settings, Anamnèse offers tools for care coordination, digitizing patient journeys, and telecare, which helps in managing unscheduled care and reducing the burden on emergency services. In the preventive medicine sector, the platform is used for applications such as identifying psychosocial risks among employees or students. Revenue is generated through these tailored software solutions that address specific client needs, such as managing clinical trials, coordinating multi-professional care, and deploying social barometers within companies.
Anamnèse has developed a unique technological asset called the Medical Knowledge Graph (MKG), an explainable AI that models medical reasoning. This technology powers the platform's intelligent patient questionnaires, which help in accelerating the detection of pathologies and facilitating patient care and orientation. The platform is designed to be modular, allowing for the rapid assembly of various components like appointment scheduling, teleconsultation, and remote monitoring to create customized patient journeys. The product suite includes three main solutions: CITANA for coordinated outpatient care, MEDANA for optimizing e-health pathways in hospitals, and PREVANA for health prevention in organizations. These solutions are GDPR compliant and health data is securely hosted on certified servers in France.
Keywords: e-health solutions, digital health platform, patient pathway digitization, medical AI, care coordination software, preventive medicine technology, SaaS for healthcare, teleconsultation, remote patient monitoring, clinical trial software, Medical Knowledge Graph, psychosocial risk detection, healthcare efficiency, outpatient care management, hospital e-health, Jérôme Bourreau, École Polytechnique, digital transformation healthcare, medical reasoning modeling, patient engagement tools